Evaluation of molecular sputum test diagnostic for lung cancer

Evaluation of molecular sputum test diagnostic for lung cancer - Lung cancer sputum test

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON38180

Enrollment

600

Registered

2008-11-26

Start date

2009-05-01

Completion date

Unknown

Last updated

2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bronchus carcinoma

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: patients suspicious of lung cancer; Patients with progression of lung cancer after treatment

Exclusion criteria

Exclusion criteria: No

Design outcomes

Primary

Measure	Time frame
Primary research variables A) Establish effect of prolonged sputum sampling on sensitivity for diagnosis of lung cancer. B) Establish clinical sensitivity and specificity of molecular sputum test for the diagnosis of lung cancer in symptomatic patients, and comparison of molecular test with cytological examination. C) Establish clinical sensitivity and specificity of molecular sputum test for early diagnosis of lung cancer	—

Measure

Time frame

Primary research variables A) Establish effect of prolonged sputum sampling on sensitivity for diagnosis of lung cancer. B) Establish clinical sensitivity and specificity of molecular sputum test for the diagnosis of lung cancer in symptomatic patients, and comparison of molecular test with cytological examination. C) Establish clinical sensitivity and specificity of molecular sputum test for early diagnosis of lung cancer

—

Secondary

Measure	Time frame
A) Establish in subpopulation analysis of exhaled air. B) Establish in subpopulation analysis molecular markers in blood for comparison with sputum.	—

Countries

Netherlands

Outcome results